Christine S Rollier

10PUBLICATIONS
68CO-AUTHORS
Animal protection (incl. pests and pathogens)Medical infection agents (incl. prions)Medical molecular engineering of nucleic acids and proteinsInnate immunityNgā tikanga mātauranga o te Māori (Māori educational methods)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|May 30, 2026
Pathogen-specific immune responses might underlie divergent outcomes of coronavirus and influenza infection in the natural porcine host.

|May 07, 2025
A phase 1/2a clinical trial to assess safety and immunogenicity of an adenoviral-vectored capsular group B meningococcal vaccine.

Christina Dold, Blanché Oguti, Laura Silva-Reyes

|Jun 21, 2023
An adenoviral-vectored vaccine confers seroprotection against capsular group B meningococcal disease.

Christina Dold, Leanne Marsay, Nelson Wang

|Jan 26, 2022
Human B Cell Responses to Dominant and Subdominant Antigens Induced by a Meningococcal Outer Membrane Vesicle Vaccine in a Phase I Trial.

Christine S Rollier, Christina Dold, Leanne Marsay

|Jan 29, 2021
MAIT cell activation augments adenovirus vector vaccine immunogenicity.

Nicholas M Provine, Ali Amini, Lucy C Garner

|Dec 18, 2020
Phase 1/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responses.

Jordan R Barrett, Sandra Belij-Rammerstorfer, Christina Dold

Pageof 2

Frequent Collaborators

6 joint publications

Andrew J Pollard

4 joint publications

Adrian V S Hill

3 joint publications

Teresa Lambe

2 joint publications

Daniel Jenkin